These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6797471)

  • 1. Activation of intrinsic blood coagulation by ellagic acid: insoluble ellagic acid-metal ion complexes are the activating species.
    Bock PE; Srinivasan KR; Shore JD
    Biochemistry; 1981 Dec; 20(25):7258-66. PubMed ID: 6797471
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human plasma prekallikrein: influence of activators, activation time and temperature and inhibitors.
    Amundsen E; Gallimore MJ; Aasen AO; Larsbraaten M; Lyngaas K
    Thromb Res; 1978 Oct; 13(4):625-36. PubMed ID: 746527
    [No Abstract]   [Full Text] [Related]  

  • 4. Contact activation by ellagic acid - the concept of soluble activator disputed.
    Exner T; Rickard KA
    Thromb Res; 1982 Apr; 26(2):83-9. PubMed ID: 7112511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some cardiovascular and hematological changes induced in the rat by activation of Hageman factor with ellagic acid.
    Damas J; Remacle-Volon G; Adam A
    Adv Exp Med Biol; 1989; 247A():461-5. PubMed ID: 2603812
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of ellagic acid and heparin on coagulation, fibrinolysis and metastasis in traumatized animals (author's transl)].
    Agostino D; Agostino N
    Sangre (Barc); 1980; 25(6):989-98. PubMed ID: 7221832
    [No Abstract]   [Full Text] [Related]  

  • 7. [Flavellagic acid influence on blood coagulation and hemostasis disturbed by whole body irradiation].
    Pospísil J; Skala E; Zitko M; Dienstbier Z
    Strahlentherapie; 1983 May; 159(5):299-305. PubMed ID: 6344348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of clot-promoting and amidolytic activities in mixtures of Hageman factor (factor XII) and ellagic acid.
    Ratnoff OD; Saito H
    J Lab Clin Med; 1982 Aug; 100(2):248-60. PubMed ID: 7097109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Haemostatic action of flavellagic acid in rats subjected to whole-body irradiation (author's transl)].
    Pospísil J; Klir P; Zitko M; Jarý J; Dienstbier Z
    Sb Lek; 1979 Oct; 81(10):302-10. PubMed ID: 515676
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of ellagic acid-activated Hageman factor (factor XII) and Hageman factor fragments by popcorn inhibitor.
    Ratnoff OD; Moneme V
    Proc Soc Exp Biol Med; 1981 Feb; 166(2):297-9. PubMed ID: 7208489
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombus weight as a measure of hypercoagulability induced by drugs.
    MacIomhair M; Lavelle SM
    Thromb Haemost; 1979 Oct; 42(3):1018-21. PubMed ID: 505392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.
    Joist JH; Cowan JF; Khan M
    J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ellagic acid/phospholipid-induced coagulation and dextran sulfate-induced fibrinolytic activities in beta 2-glycoprotein I-depleted plasma.
    Shiozaki A; Niiya K; Higuchi F; Tashiro S; Arai T; Izumi R; Sakuragawa N
    Thromb Res; 1994 Oct; 76(2):199-210. PubMed ID: 7863469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the vascular and hematological changes induced by ellagic acid in rats.
    Damas J; Adam A; Remacle-Volon G; Grek V
    Agents Actions; 1987 Dec; 22(3-4):270-9. PubMed ID: 3445821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of pulmonary metastases following the intravenous infusion of a suspension of ellagic acid in traumatized rats.
    Agostino D; Agostino N
    Tumori; 1980 Jun; 66(3):285-93. PubMed ID: 7445109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosoma mansoni: effect of some cations on the proteolytic enzymes of cercariae.
    Dresden MH; Edlin EM
    Exp Parasitol; 1974 Apr; 35(2):299-303. PubMed ID: 4206936
    [No Abstract]   [Full Text] [Related]  

  • 17. [Test for detection of activated partial thromboplastin time using ellagic acid].
    Berkovskiĭ AL; Sergeeva EV; Kachalova ND; Prostakova TM; Kozlov AA
    Klin Lab Diagn; 1999 Jun; (6):18-20. PubMed ID: 10459199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Action of purified ellagic acid on coagulation time, compared with crude ellagic acid].
    Girolami A
    Haematologica; 1966; 51(2):96-102. PubMed ID: 4957869
    [No Abstract]   [Full Text] [Related]  

  • 19. [Toxicity and effect of flavellagic acid on blood coagulation and haemostasis in healthy rabbits and rabbits exposed to whole-body irradiation (author's transl)].
    Pospísil J; Klír P; Skala E; Vranovská J; Dienstbier Z
    Sb Lek; 1982 Apr; 84(4):115-21. PubMed ID: 7100810
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.